Unknown

Dataset Information

0

Quantification of Protein Secretion from Circulating Tumor Cells in Microfluidic Chambers.


ABSTRACT: Cancer cells can be released from a cancerous lesion and migrate into the circulatory system, from whereon they may form metastases at distant sites. Today, it is possible to infer cancer progression and treatment efficacy by determining the number of circulating tumor cells (CTCs) in the patient's blood at multiple time points; further valuable information about CTC phenotypes remains inaccessible. In this article, a microfluidic method for integrated capture, isolation, and analysis of membrane markers as well as quantification of proteins secreted by single CTCs and CTC clusters is introduced. CTCs are isolated from whole blood with extraordinary efficiencies above 95% using dedicated trapping structures that allow co-capture of functionalized magnetic beads to assess protein secretion. The patform is tested with multiple breast cancer cell lines spiked into human blood and mouse-model-derived CTCs. In addition to immunostaining, the secretion level of granulocyte growth stimulating factor (G-CSF), which is shown to be involved in neutrophil recruitment, is quantified The bead-based assay provides a limit of detection of 1.5 ng mL-1 or less than 3700 molecules per cell. Employing barcoded magnetic beads, this platform can be adapted for multiplexed analysis and can enable comprehensive functional CTC profiling in the future.

SUBMITTER: Armbrecht L 

PROVIDER: S-EPMC7284199 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Quantification of Protein Secretion from Circulating Tumor Cells in Microfluidic Chambers.

Armbrecht Lucas L   Rutschmann Ophélie O   Szczerba Barbara Maria BM   Nikoloff Jonas J   Aceto Nicola N   Dittrich Petra S PS  

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 20200424 11


Cancer cells can be released from a cancerous lesion and migrate into the circulatory system, from whereon they may form metastases at distant sites. Today, it is possible to infer cancer progression and treatment efficacy by determining the number of circulating tumor cells (CTCs) in the patient's blood at multiple time points; further valuable information about CTC phenotypes remains inaccessible. In this article, a microfluidic method for integrated capture, isolation, and analysis of membran  ...[more]

Similar Datasets

| S-EPMC4266859 | biostudies-literature
| S-EPMC4664604 | biostudies-literature
| S-EPMC9266647 | biostudies-literature
| S-EPMC7231302 | biostudies-literature
| S-EPMC9995442 | biostudies-literature
| S-EPMC4179254 | biostudies-literature
| S-EPMC4770429 | biostudies-literature
| S-EPMC3987064 | biostudies-other
| S-EPMC5859469 | biostudies-literature
| S-EPMC3364832 | biostudies-other